Joshua J. Neumiller, PharmD, CDCES, of the American Diabetes Association, discusses pharmacists’ role in diabetes and CKD care at ASN Kidney Week 2026.
|Videos|August 16, 2015
Optimal Strategies to Support OTC Management of URTIs
Erin Dorval, PharmD, community assistant professor of pharmacy practice at Palm Beach Atlantic University, talks about ways that pharmacists can help management of URTIs.
Advertisement
Erin Dorval, PharmD, community assistant professor of pharmacy practice at Palm Beach Atlantic University, talks about ways that pharmacists can help management of URTIs.
This video was filmed at CHPC 2015.
Advertisement
Related to this article
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
ADA guidance ties monitoring choices to therapy, risk, and preference. Brooke Hudspeth, PharmD, explains how pharmacists help individualize the plan.
The provider-administered IL-23 inhibitor improved ACR20 response vs placebo after 2 doses in the phase 3 INSPIRE-1 and INSPIRE-2 trials.
Two Kidney Week 2026 posters suggest remnant cholesterol–based markers may help stratify CKD severity and cardiovascular death risk on hemodialysis.
Treated patients also had fewer post-acute hospitalizations and deaths, but individuals without risk factors saw no benefit.
A pharmacy technician reflects on 3 patient encounters that reshaped his
understanding of what a real patient requires.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Community Pharmacists Guide Patients New to Glucose Monitoring
2
FDA Approves Tildrakizumab for Adults With Psoriatic Arthritis
3
Is Less More? Comparing Metronidazole Dosing in Confirmed Anaerobic Infections
4
Long-Term Care Pharmacies Can Close the Flu Vaccination Gap Among Older Adults
5